[1. Thenappan T, Ormiston M, Ryan J, Archer S. Pulmonary arterial hypertension: pathogenesis and clinical management. BMJ. 2018;360:j5492.10.1136/bmj.j5492688997929540357]Search in Google Scholar
[2. Rabinovitch M, Guignabert C, Humbert M, Nicolls MR. Inflammation and Immunity in the Pathogenesis of Pulmonary Arterial Hypertension. Circulation Research. 2014;115:165-175.10.1161/CIRCRESAHA.113.301141409714224951765]Search in Google Scholar
[3. El Chami H, Hassoun PM. Immune and Inflammatory Mechanisms in Pulmonary Arterial Hypertension. Progress in Cardiovascular Diseases. 2012;55:218-228.10.1016/j.pcad.2012.07.006345918023009917]Search in Google Scholar
[4. Ryan JJ, Archer SL. The Right Ventricle in Pulmonary Arterial Hypertension: Disorders of metabolism, angiogenesis and adrenergic signaling in right ventricular failure. Circulation Research. 2014;115:176-188.10.1161/CIRCRESAHA.113.301129411229024951766]Search in Google Scholar
[5. Naejie R, Manes A. The right ventricle in pulmonary arterial hypertension. European Respiratory Review. 2014;23:476-487.10.1183/09059180.0000741425445946]Search in Google Scholar
[6. Simonneau G, Gatzoulis MA, Adatia I, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2013;62(25 Suppl):D34-41.10.1016/j.jacc.2013.10.02924355639]Search in Google Scholar
[7. Engelfriet P, Meijboom F, Boersma E, Tijssen J, Mulder B. Repaired and open atrial septal defects type II in adulthood: an epidemiological study of a large European cohort. Int J Cardiol. 2008;126:379-385.10.1016/j.ijcard.2007.04.04417586067]Search in Google Scholar
[8. Post MC. Association between pulmonary hypertension and an atrial septal defect. Netherlands Heart Journal. 2013;21:331-332.10.1007/s12471-013-0432-9372238823737246]Search in Google Scholar
[9. Damy T, Goode KM, Kallvikbacka-Bennett A, et al. Determinants and prognostic value of pulmonary arterial pressure in patients with chronic heart failure. Eur Heart J. 2010;31:2280-2290.10.1093/eurheartj/ehq24520693169]Search in Google Scholar
[10. Delgado JF, Conde E, Sánchez V, et al. Pulmonary vascular remodeling in pulmonary hypertension due to chronic heart failure. Eur J Heart Fail. 2005;7:1011-1016.10.1016/j.ejheart.2004.10.02116227139]Search in Google Scholar
[11. Hoeper MM. Pulmonary hypertension in collagen vascular disease. Eur Respir J. 2002;19:571-576.10.1183/09031936.02.0151200111936539]Search in Google Scholar
[12. Mukerjee D, St George D, Coleiro B, et al. Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach. Ann Rheum Dis. 2003;62:1088-1093.10.1136/ard.62.11.1088175435314583573]Search in Google Scholar
[13. Fisher MR, Mathai SC, Champion HC, et al. Clinical differences between idiopathic and scleroderma-related pulmonary hypertension. Arthritis &Rheumatology. 2006;54:3043-3050.10.1002/art.2206916947776]Search in Google Scholar
[14. Benedek T, Opincariu D, Rat N, Hodas R, Mester A, Benedek I. The Assessment of Epicardial Adipose Tissue in Acute Coronary Syndrome Patients. A Systematic Review. Journal of Cardiovascular Emergencies. 2017;3:18-29.10.1515/jce-2017-0003]Search in Google Scholar
[15. Mahabadi A, Berg M, Lehmann N, et al. Association of Epicardial Fat With Cardiovascular Risk Factors and Incident Myocardial Infarction in the General Population: The Heinz Nixdorf Recall Study. J Am Coll Cardiol. 2013;61:1388-1395.10.1016/j.jacc.2012.11.06223433560]Search in Google Scholar
[16. Torres T, Bettencourt N, Mendonça D, et al. Epicardial adipose tissue and coronary artery calcification in psoriasis patients. J Eur Acad Dermatol Venereol. 2015;29:270-277.10.1111/jdv.1251624750319]Search in Google Scholar
[17. Lima-Martinez MM, Campo E, Salazar J, et al. Epicardial fat thickness as cardiovascular risk factor and therapeutic target in patients with rheumatoid arthritis treated with biological and nonbiological therapies. Arthritis. 2014;2014:782850.10.1155/2014/782850427669625574390]Search in Google Scholar
[18. Long BD, Stojanovska J, Brown R, Attilli A, Jackson E, Ognenovski V. Increased Epicardial Fat Volume Is Independently Associated with the Presence and Severity of Systemic Sclerosis. Acad Radiol. 2017;24:1473-1481.10.1016/j.acra.2017.07.003572527028847640]Search in Google Scholar
[19. Kaplan O, Kurtoglu E, Gozubuyuk G, et al. Epicardial adipose tissue thickness in patients with chronic obstructive pulmonary disease having right ventricular systolic dysfunction. Eur Rev Med Pharmacol Sci. 2015;19:2461-2467.]Search in Google Scholar
[20. Gul I, Zungur M, Aykan A, et al. The relationship between GRACE score and Epicardial Fat thickness in non-STEMI Patients. Arq Bras Cardiol. 2016;106:194-200.10.5935/abc.20160024481127426885974]Search in Google Scholar
[21. Ozcan F, Turak O, Canpolat U, et al. Association of epicardial fat thickness with TIMI risk score in NSTEMI/USAP patients. Herz. 2013;39:755-760.10.1007/s00059-013-3914-z23903366]Search in Google Scholar
[22. Wang T, Liu Q, Liu C, et al. Correlation of Echocardiographic Epicardial Fat Thickness with Severity of Coronary Artery Disease in Patients with Acute myocardial infarction. Echocardiography. 2014;31:1177-1181.10.1111/echo.1254524645963]Search in Google Scholar
[23. Mazurek T, Zhang L, Zalewski A, et al. Human epicardial adipose tissue is a source of inflammatory mediators. Circulation. 2003;108:2460-2466.10.1161/01.CIR.0000099542.57313.C514581396]Search in Google Scholar
[24. Fatma E, Bunyamin K, Savas S, et al. Epicardial fat thickness in patients with rheumatoid arthritis. African Health Sciences. 2015;15:489-495.10.4314/ahs.v15i2.23448047826124795]Search in Google Scholar